Study identifier:D133FR00199
ClinicalTrials.gov identifier:NCT06188494
EudraCT identifier:N/A
CTIS identifier:N/A
A Multicenter, Observational, Secondary data collection, Retrospective, National Study to Assess the Prevalence of HER2-low Breast Cancer Among Patients Previously Diagnosed with Unresectable and/or Metastatic HER2-Negative Breast Cancer in Egypt – UNFOLD
Breast Cancer
N/A
No
-
All
400
Observational
n/a - n/a
Allocation: N/A
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -
Verified 01 Dec 2024 by AstraZeneca
AstraZeneca
-
No locations available
Arms | Assigned Interventions |
---|